ACR 2024 highlighted new guidelines for the screening, treatment, and management of lupus nephritis, stressing prompt kidney biopsy and timely treatment.

biopsy-proven lupus nephritis (class III-V) and evidence of active disease (e.g. elevated serum creatinine concentration, proteinuria or microscopic hematuria), were prospectively recruited in ...

WASHINGTON — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) medications appear beneficial for people with systemic lupus erythematosus (SLE) and lupus nephritis, two new studies suggest.

GLP-1 RAs might lower kidney failure risk in patients with lupus nephritis by reducing pro-inflammatory ... GLP-1 RAs are a new class of anti-hyperglycemic drugs shown to be beneficial in reducing ...

including lupus nephritis, was admitted to hospital with intractable back pain accompanied by fever and severe malaise. At the time of presentation she was receiving immunosuppressive treatment ...

GLP-1 receptor agonist use is associated with benefits in a number of different disease and may help treat patients with lupus nephritis.